Tisch Cancer Institute at Mount Sinai

 

WCLC 2022 Conference Coverage
T

Lecture Summary - WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes With PD-L1 Blockade to Reverse Type-2 Mediated Immunosuppression

By WCLC 2022 Conference Coverage FEATURING Thomas Marron
By WCLC 2022 Conference Coverage FEATURING Thomas Marron
13 views
September 6, 2022
Comments 0
Login to view comments. Click here to Login
Videos
05:46

ASH 2024 Insights: Updated Ph3 MANIFEST-2 Results - Pelabresib + Rux…

2024 ASH Annual Meeting Insights Hub

J. Mascarenhas

123 views
11:06

ASH 2024 Insights: Ph3 BOREAS Study - Navtemadlin vs. Best Available…

2024 ASH Annual Meeting Insights Hub

J. Mascarenhas

54 views
15:23

Non Immune-Based Approaches for Advanced Myeloma

Tisch Cancer Institute at Mount Sinai

G. Kaur

98 views
06:30

ASTRO 2023 Insights: "Treatment Landscape for mCRPC - Lu-177-PSMA, R…

Tisch Cancer Institute at Mount Sinai

W. Oh

203 views
10:51

SOHO 2023 Next Questions: Myeloproliferative Neoplasms

SOHO 2023 Eleventh Annual Meeting

J. Mascarenhas

67 views
17:34

SOHO 2023: Novel Non-JAK Inhibitor Therapies for Myelofibrosis

SOHO 2023 Eleventh Annual Meeting

J. Mascarenhas

233 views
01:07

Lecture Summary - WCLC 2022 on Cancer and Atopy: Parallel Drivers? I…

WCLC 2022 Conference Coverage

T. Marron

13 views
11:14

WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Syner…

WCLC 2022 Conference Coverage

T. Marron

52 views
09:41

Managing Symptom Burden and Optimizing Treatment Outcomes in Myelofi…

i3 Health

J. Mascarenhas

97 views
05:07

TKI in the Management of Advanced HCC

Icahn School of Medicine at Mount Sinai

A. Villanueva

237 views
11:42

Symptom Assessments in Myelofibrosis and How to Examine the Spleen

Icahn School of Medicine at Mount Sinai

M. Kremyanskaya

73 views
04:20

The Roles of Etiology and Biopsy in Hepatocellular Carcinoma

Oncology Data Advisor

A. Villanueva

34 views
20:43

PD-L1 Expression: Practical Implications in Advanced Stage NSCLC

Tisch Cancer Institute at Mount Sinai

F. Hirsch

198 views
07:13

FDA Approval and Safety Analysis of Pacritinib in Patients With Myel…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

165 views
06:20

Retrospective Head-to-Head Comparison Between Pacritinib and Ruxolit…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

117 views
05:04

ASCO GI 2022 Updates on IO for Early Stage HCC

ASCO GI 2022 Conference Coverage

A. Villanueva

173 views
15:25

ASH 2021 Clinical and Translational Data From the Ongoing MANIFEST T…

ASH 2021 Conference Coverage on VuMedi

M. Kremyanskaya

92 views
07:56

ASH 2021 Rationale for and Results of a Phase I Study of the TGF-β 1…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

57 views
05:15

ASH 2021 Update on Clinical Outcomes at 3 and 6 Months of Fedratinib…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

622 views
21:07

Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…

2021 International Congress on Myeloproliferative Neoplasms

J. Mascarenhas

18 views
01:47

2021 ASCO Summary on COVID-19 & Cancer

2021 ASCO Virtual Direct™ Highlights

D. Doroshow

10 views
08:32

2020 NSCLC Update: Does PD-L1 Predict Pembrolizumab Response in Pati…

Tisch Cancer Institute at Mount Sinai

D. Doroshow

166 views
06:49

Can Pacritinib Be Used to Treat Cytokine Storm in Patients With COVI…

Tisch Cancer Institute at Mount Sinai

J. Mascarenhas

3.1K views
28:34

Managing Hepatocellular Carcinoma: Early Detection and Diagnosis, St…

Tisch Cancer Institute at Mount Sinai

A. Villanueva

364 views
07:57

Epidemiology of Hepatocellular Carcinoma: Disease Burden and Trends

Tisch Cancer Institute at Mount Sinai

A. Villanueva

86 views
11:35

Clinical Challenges in Management of Hepatocellular Carcinoma: Liqui…

Tisch Cancer Institute at Mount Sinai

A. Villanueva

55 views
24:22

Update on Clinical Trials in Myeloproliferative Neoplasms

Tisch Cancer Institute at Mount Sinai

J. Mascarenhas

398 views